West Pharmaceutical Services, Inc. (WST)
West Pharmaceutical Services, Inc. Operating Income 2008–2025
West Pharmaceutical Services, Inc. annual/quarterly operating income history and growth rate from 2008 to 2026. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- West Pharmaceutical Services, Inc. operating income for the quarter ending March 31, 2026 was 177.1 M, a 65.51% increase year-over-year.
- West Pharmaceutical Services, Inc. operating income for the twelve months ending March 31, 2026 was 605.4 M, a 3.03% increase year-over-year.
- West Pharmaceutical Services, Inc. annual operating income for 2025 was 584.9 M, a 2.63% increase from 2024.
- West Pharmaceutical Services, Inc. annual operating income for 2024 was 569.9 M, a 15.70% decrease from 2023.
- West Pharmaceutical Services, Inc. annual operating income for 2023 was 676.0 M, a 7.90% decrease from 2022.
- West Pharmaceutical Services, Inc. annual operating income for 2022 was 734.0 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
West Pharmaceutical Services, Inc. Operating Income — FAQ
West Pharmaceutical Services, Inc. (WST) operating income over the last 18 years — annual and quarterly figures with year-over-year growth and charts.
What is West Pharmaceutical Services, Inc.'s operating income?
West Pharmaceutical Services, Inc. (WST) reported operating income of $585M for fiscal 2025.
Where can I see WST's operating income history?
The chart and table above show West Pharmaceutical Services, Inc.'s operating income by year and by quarter, including the growth rate.